Plan your art weekend in the Klang Valley with these five shows
Haiku-inspired video essays to Red Hong Yi's Memebank art project are the weekend's art highlights in the Klang Valley
Source: thestar.com.my
📰 John Long News
Page 52 - John Long News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Long. Real-time updates on events, politics, business and more.
Connecting recovery zones may benefit grizzly populations
Grizzlies have made gains toward recovery, but populations may need to connect to secure long-term stability. That has prompted scientists to focus on lands that fall between large populations.
Source: journalnow.com
Connecting recovery zones may benefit grizzly populations
Grizzlies have made gains toward recovery, but populations may need to connect to secure long-term stability. That has prompted scientists to focus on lands that fall between large populations.
Source: hickoryrecord.com
Readers react after driver seen 'speeding at 98mph' on Rainford bypass
STAR readers have called for action to reduce speeding on the Rainford bypass after police reported a driver on the road.
Source: sthelensstar.co.uk
I-Mab Announces Execution of Senior Management Team Share Purchase Plan
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com
I-Mab Announces Execution of Senior Management Team Share Purchase Plan
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors
SHANGHAI and GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- I-Mab (the Company) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com...
Source: businessinsider.com
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com